(MT Newswires) -- Dutch Philips Group (PHG) CEO Roy Jakobs discusses the consequences of the sleep apnea machine recall. The Dutch medical equipment manufacturer has not given a definitive figure for the cost of the recall, as the legal proceedings are not over, but claims that 99% of defective devices have been replaced. While the company has recorded three consecutive quarters of growth, it points to investments in artificial intelligence, estimated at over a billion euros a year.
Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO
![Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO](https://cdn.zonebourse.com/static/resize/464/261/https://www.zonebourse.com/images/ImagesTagged/zbimg_2908536_800.png)
![mtnewswires logo](/images/mtnewswires.png)